Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.59 USD | -0.70% | -8.67% | +133.83% |
Apr. 11 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
Apr. 03 | Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer | CI |
Chart calendar Q32 Bio Inc.
Upcoming events on Q32 Bio Inc.
No events available
Past events on Q32 Bio Inc.
2023-11-14 04:33 pm | Q3 2023 Earnings Release |
2023-08-14 04:05 pm | Q2 2023 Earnings Release |
2023-07-27 04:30 pm | Business Update Call |
2023-06-13 | Annual General Meeting |
2023-05-24 | World Orphan Drug Congress |
2023-05-19 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract # 1312 |
2023-05-19 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract # 1497 |
2023-05-19 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract # 1355 |
2023-05-18 03:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract # 989 |
2023-05-17 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract # 376 |
2023-05-17 03:00 pm | American Society of Gene Cell Therapy Meeting - Abstract # 386 |
2023-05-11 04:05 pm | Q1 2023 Earnings Release |
2023-03-17 12:30 pm | ACMG Clinical Genetics Meeting |
2023-03-16 12:30 pm | ACMG Clinical Genetics Meeting |
2023-03-13 | ACMG Clinical Genetics Meeting |
2023-03-11 02:30 pm | Project Alive Hunter Syndrome Community Conference |
2023-03-09 04:05 pm | Q4 2022 Earnings Release |
2023-03-08 10:30 am | Cowen Health Care Conference - Panel |
2022-11-15 04:10 pm | Stifel Healthcare Conference |
2022-11-10 04:07 pm | Q3 2022 Earnings Release |
Annual results
Fiscal Period | December | 2023 | 2024 |
---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -49,6 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -51,1 |
Net income Million USD | Released Forecast Spread | -53,7 | -51,1 |
EPS USD | Released Forecast Spread | -7,41 | -4,37 |
Announcement Date | 27/03/24 | - |
Quarterly results
Fiscal Period | December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -11,9 | -12,2 | -12,5 | -12,8 | -13,7 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,9 | -11,7 | -12,1 | -12,4 | -13,7 |
Net income Million USD | Released Forecast Spread | -14,9 | -11,7 | -12,1 | -12,4 | -13,7 |
EPS USD | Released Forecast Spread | -1,42 | -0,98 | -1,01 | -1,04 | -0,80 |
Announcement Date | - | - | - | - | - |
Today 07:00 am | BIOCRYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Today 04:01 pm | VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release |
2024-05-06 | COGENT BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-06 | LYELL IMMUNOPHARMA, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-06 | Y-MABS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-06 | INNOCARE PHARMA LIMITED: Q1 2024 Earnings Release (Projected) |
2024-05-06 | PHILOGEN S.P.A.: Q1 2024 Earnings Release |
2024-05-07 07:00 am | RHYTHM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-07 07:00 am | MADRIGAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-07 04:01 pm | HALOZYME THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Past sector events for Q32 Bio Inc.
Today | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected) |
Today | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
Today | MERUS N.V.: Q1 2024 Earnings Release (Projected) |
Today | VAXCYTE, INC.: Q1 2024 Earnings Release (Projected) |
Today | INHIBRX, INC.: Q1 2024 Earnings Release (Projected) |
Today | BIONTECH SE: Q1 2024 Earnings Release |
2024-05-03 07:00 am | GH RESEARCH PLC: Q1 2024 Earnings Release |
2024-05-02 04:05 pm | KURA ONCOLOGY, INC.: Q1 2024 Earnings Release |
2024-05-02 04:05 pm | ZYMEWORKS INC.: Q1 2024 Earnings Release |
2024-05-02 04:02 pm | ARDELYX, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- QTTB Stock
- Calendar Q32 Bio Inc.